Navigation Links
Study begins to reveal clues to the cause and progression of sepsis
Date:8/13/2007

PITTSBURGH, Aug. 13 Not all patients with sepsis mount the same immune response, even when they look the same clinically, according to findings from the first large-scale natural history study of sepsis. The results, published by University of Pittsburgh School of Medicine researchers in the August 13/27 issue of the Archives of Internal Medicine, indicate that past interpretations of how the immune system responds to infection interpretations on which many experimental treatments were based were incorrect.

This year, nearly 1 million Americans will develop sepsis, a result of the bodys inflammatory response to an infection, which can lead to organ failure and death. More than 30 percent will die, making sepsis the 10th leading cause of death. While incidence rates of sepsis have been steadily increasing over the years, little is known about the condition. Past investigational treatments have been based on data from small studies, and most of these therapies have failed.

Researchers at the University of Pittsburgh believe that these treatments failed, at least in part, because of insufficient data to fully understand the complexity and variability of the inflammatory response to sepsis. To gain a better understanding into the mechanisms behind the condition, the researchers conducted the Genetic and Inflammatory Markers of Sepsis study (GenIMS), which collected extensive clinical and laboratory data geared to help analyze the risks of a person developing sepsis and dying. Data were collected from 2,320 subjects who came to hospital emergency rooms at 28 sites nationwide.

With sepsis, were dealing with one of the deadliest diseases, yet we know so little about the condition. The situation is similar to what this country experienced over 50 years ago with heart disease and stroke we knew that too many people were dying of cardiovascular disease, but we didnt know enough about the disease to effectively treat and prevent it, s
'/>"/>

Contact: Jocelyn Uhl Duffy
UhlJH@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Bioartificial kidney under study at MCG
2. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
3. W.M. Keck Foundation funds study of friendly microbes
4. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
5. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
6. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
7. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
8. Study Links Ebola Outbreaks To Animal Carcasses
9. Genome-wide mouse study yields link to human leukemia
10. Breakthrough Microarray-based Technology for the Study of Cancer
11. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... training grant in the amount of $2,756,719 by the... Graduation Education and Research Training (IGERT...rded to Kent State. The grant, which is funded und...009, runs through 2014. , The grant funds an IGE...ource sensing (EARS). The purpose of the program i...
(Date:11/4/2009)... Long Beach and Riverside are responsible for a si...ma, and the true impact of air pollution and ship ...mated, according to researchers at the University ...h appears in an online edition of the American Jo...nt of all childhood asthma cases in Long Beach and...
(Date:11/4/2009)... the DNA codes, or genomes, of the famed fugu (or ...ome 10K Project, an international effort to build ...0 species of animals for conducting comparative st...d. , Participating in The Genome 10K project, de...ssue of the Journal of Heredity , are 70 leading ...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2USC study finds big air pollution impacts on local communities 2Singapore scientists join international study of 10,000 vertebrates' genomes 2Re define 26apos 3BThank You 26apos 3B With Style and Value From Van 26apos 3Bs Gifts 59916 1Re define 26apos 3BThank You 26apos 3B With Style and Value From Van 26apos 3Bs Gifts 59916 2Committed Time and Personal Passion 3A Key Traits Among ABL 26apos 3Bs Award Finalists 59912 1Committed Time and Personal Passion 3A Key Traits Among ABL 26apos 3Bs Award Finalists 59912 2Committed Time and Personal Passion 3A Key Traits Among ABL 26apos 3Bs Award Finalists 59912 3Committed Time and Personal Passion 3A Key Traits Among ABL 26apos 3Bs Award Finalists 59912 4Dr Philip Katz Elected President of the American College of Gastroenterology 59908 1Dr Philip Katz Elected President of the American College of Gastroenterology 59908 2Dr Philip Katz Elected President of the American College of Gastroenterology 59908 3
... take soy or herbal supplements, such as black coh...e, says a Cornell University expert affiliated wit...isk Factors (BCERF) at Cornell, the land-grant ins...o direct evidence that any herbal medicines can in...can have estrogen-like actions and thus raise conc...
...s in the US could soon be asked to approve a human...es a hybrid of the HIV and Ebola viruses. Tests on...he lungs far more efficiently than any other metho...g two killer viruses sounds horrifying, the risks ...anaged to develop an effective form of gene therap...
...rough in human stem cell research, producing embry...tantially speed up the development of treatments f...lities. The discovery made during a project undert...ical Branch and the Synthecon Corporation in the U...icians with an ethical and reliable source of huma...
Other Biology News:Menopause Symptoms May Come Back After Stopping Menopausal Hormone Therapy 2Menopause Symptoms May Come Back After Stopping Menopausal Hormone Therapy 3Can two killers make a cure? 2Insight into the processes of 'positive' and 'negative' learners 2
(Date:11/6/2009)...v. 6 ,, 3Q09 Corpo...tenza(TM) E.U. Marketing Authorization to Astellas... commercial readiness activities Expanded managem...keting; and Director, Commercial Operations Appoi...Audit Committee chairman , Upcoming 2009 Mi...
(Date:11/6/2009)...he agenda for Arrowhead’s 2010 Personalized ...take place on February 22-24, 2010 in Philadelphia... we will highlight key issues in forming partnersh...periences. , Minneapolis,...owhead’s 2010 Personalized Medicine Partner...
(Date:11/5/2009).... 5 DSM Pharmaceutical Products to...iance with Galenix, Saint Jean D,Illac, France, wh...ufacturing partner for Galenix commercial products...laborate on business development opportunities co-...d on the strength of Galenix in drug product devel...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC B...ults for the quarter ended September 30, 2009. The...tables that follow. ,, Third Quarter 2009 ,...$0.01 per share for the third quarter of 2009 as c...re for the third quarter of 2008. ,, Net sales...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
... Praha, Czech Republic www.dataapex.com , ...mer Institute SAV, Bratislava, Slovak Republic, ...tion of MW distribution of polymers by the liquid ...,selective detectors is a simple, affordable sol...development of,synthetic and natural polymers. A...
...mended Cecil Instrument: , Cecil Biocompatib...al biocompatible autosampler which will accommoda...t is required. A fraction collector may be added...is an ion-pair reversed-phase high-performance li...It identifies mutations and polymorphisms based o...
...onomical RNAi screening , , Fl...exible RNAi screening. , FlexiPlate siRNA... scales , in 96-well plates for your choi... select siRNAs and specify plate layout at th... , Advantages of FlexiPlate siRNA: ,...
Other Biology Technology:Practical Aspects of Evaluation of Chromatographic Data in Size Exclusion Chromatography 2Practical Aspects of Evaluation of Chromatographic Data in Size Exclusion Chromatography 3Practical Aspects of Evaluation of Chromatographic Data in Size Exclusion Chromatography 4Practical Aspects of Evaluation of Chromatographic Data in Size Exclusion Chromatography 5Denaturing HPLC (DHPLC) 2Denaturing HPLC (DHPLC) 3FlexiPlate siRNA 2FlexiPlate siRNA 3FlexiPlate siRNA 4
...ilZyme AP Conjugate Stabilizer is an aqueous solut...her non-toxic stabilizing chemicals in a MES buffe... This product contains a combination of 0.02% met...preservative. StabilZyme AP Conjugate Stabilizer ...
Mouse Anti-Myoglobin Monoclonal Antibody, Biotin Conjugated, Clone 4E2 from Meridian Life Science, Inc.
... nonspecific binding is a problem in your applicat...vidin products as superior alternatives to avidin ...derivative that combines several key features to p... low nonspecific binding properties. NeutrAvidin d...
BlueView Nucleic Acid Stain from Sigma-Aldrich
Biology Products: